Synchron, which is developing a brain-computer interface that helps paralysis patients text, email, and shop online, raises $40M Series B led by Khosla Ventures (Andrea Park/FierceBiotech)

Andrea Park / FierceBiotech:Synchron, which is developing a brain-computer interface that helps paralysis patients text, email, and shop online, raises $40M Series B led by Khosla VenturesAfter years of focusing on all things artificial intelligence, the buzziest buzz in medtech now centers not on robots and algorithms
Click here to read full news..

guestpostbloggingwork

websitextra

,synchron series khosla venturesparkfiercebiotech ,synchron khosla venturesparkfiercebiotech ,series khosla venturesparkfiercebiotech

Related Post

5 Major Benefits of Minimally Invasive Spine Deformity Surgery

Spine deformities such as scoliosis, kyphosis, or other conditions that affect...

Latest Post

Bold, Bright, and Botanical: How Heliconias Make Gardens Pop

Heliconia is a plant that demands attention. With vivid...

Why Malaysians Still Queue for the iPhone—Price Tag and All

Each year, the release of a new smartphone tends...

SOCIALS